INSY

Insys Therapeutics, Inc.
INSY

Delisted

INSY was delisted on the 18th of June, 2019.

113 hedge funds and large institutions have $585M invested in Insys Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.01M
Puts
$4.63M
Net Calls
Net Calls Change

Top Buyers

1 +$21.4M
2 +$12M
3 +$9.93M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.71M
5
Morgan Stanley
Morgan Stanley
New York
+$9.66M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$320K
77
$311K
78
$299K
79
$284K
80
$274K
81
$271K
82
$265K
83
$259K
84
$251K
85
$234K
86
$224K
87
$223K
88
$205K
89
$205K
90
$205K
91
$154K
92
$143K
93
$121K
94
$88K
95
$79K
96
$73K
97
$72K
98
$60K
99
$45.5K
100
$37K